Dantrolene is a direct-acting skeletal muscle relaxant categorized as a postsynaptic agent that functions by inhibiting excitation-contraction coupling through the blockage of calcium release from the… Read more












Dantrolene is a direct-acting skeletal muscle relaxant categorized as a postsynaptic agent that functions by inhibiting excitation-contraction coupling through the blockage of calcium release from the sarcoplasmic reticulum. It is primarily indicated for managing spasticity related to multiple sclerosis, cerebral palsy, and spinal cord injuries, as well as treating malignant hyperthermia. This category features critical reference standards essential for pharmaceutical analysis, including the active pharmaceutical ingredient, identified metabolites such as 5-hydroxy dantrolene, and a comprehensive range of related impurities. Laboratories utilize these high-quality compounds for method validation, routine quality control, and rigorous impurity profiling to ensure drug safety and consistency. Furthermore, stable isotope labelled versions of these materials provide vital internal standards for mass spectrometry-based assays, enabling high-precision quantification in complex matrices during analytical testing and regulatory compliance procedures.